Whole-exome sequencing of circulating tumor cells provides a window into metastatic prostate cancer

Nature Biotechnology

Volumn 32, Issue 5, 2014, Pages 479-484

  Lohr, Jens G ^a,b,c   Adalsteinsson, Viktor A ^a,d   Cibulskis, Kristian ^a   Choudhury, Atish D ^a,b,c   Rosenberg, Mara ^a   Cruz Gordillo, Peter ^a   Francis, Joshua M ^a,b   Zhang, Cheng Zhong ^a,b   Shalek, Alex K ^e   Satija, Rahul ^a   Trombetta, John J ^a   Lu, Diana ^a   Tallapragada, Naren ^d   Tahirova, Narmin ^d   Kim, Sora ^a   Blumenstiel, Brendan ^a   Sougnez, Carrie ^a   Lowe, Alarice ^f   Wong, Bang ^a   Auclair, Daniel ^a   Van Allen, Eliezer M ^a,b,c   Nakabayashi, Mari ^b,c   Lis, Rosina T ^b   Lee, Gwo Shu M ^b   Li, Tiantian ^b   Chabot, Matthew S ^b   Ly, Amy ^g   Taplin, Mary Ellen ^b,c   Clancy, Thomas E ^b,c,f   Loda, Massimo ^a,b,c,f   Regev, Aviv ^a,d,h   Meyerson, Matthew ^a,b,c   Hahn, William C ^a,b,c,f   Kantoff, Philip W ^b,c   Golub, Todd R ^a,b,c,h   Getz, Gad ^a,g   Boehm, Jesse S ^a   Love, J Christopher ^a,d   more..

^a BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^e HARVARD UNIVERSITY   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g MASSACHUSETTS GENERAL HOSPITAL   (United States)

^h HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; DISEASES; TUMORS;

CANCER GENOME; CIRCULATING TUMOR CELLS; COMPREHENSIVE ANALYSIS; GENOMICS; LYMPH NODE METASTASIS; POWER CALCULATION; PROSTATE CANCERS; TUMOR SAMPLES;

DIAGNOSIS;

ADULT; ALLELE; ARTICLE; CALCULATION; CELL ISOLATION; CIRCULATING TUMOR CELL; CLINICAL ARTICLE; CONTROLLED STUDY; EXOME; GENE MUTATION; GENE SEQUENCE; GENOMICS; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MALE; METASTASIS; MIDDLE AGED; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; VALIDATION PROCESS; GENETICS; MUTATION; PROSTATE TUMOR; TUMOR EMBOLISM;

EXOME; HUMANS; MALE; MUTATION; NEOPLASTIC CELLS, CIRCULATING; PROSTATIC NEOPLASMS;

EID: 84900333051     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt.2892     Document Type: Article

References (41)

1. Garraway, L.A. Genomics-driven oncology: framework for an emerging paradigm. J. Clin. Oncol. 31, 1806-1814 (2013).
2. International Cancer Genome Consortium. et al. International network of cancer genome projects. Nature 464, 993-998 (2010); erratum 465, 966 (2010).
3. Dawson, S.-J. et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med. 368, 1199-1209 (2013).
4. Cristofanilli, M. et al. Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer. J. Clin. Oncol. 23, 1420-1430 (2005).
5. Zhang, L. et al. The identifcation and characterization of breast cancer CTCs competent for brain metastasis. Sci. Transl. Med. 5, 180ra48 (2013).
6. Yu, M. et al. Circulating tumor cells: approaches to isolation and characterization. J. Cell Biol. 192, 373-382 (2011).
7. Cohen, S.J. et al. Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer. J. Clin. Oncol. 26, 3213-3221 (2008).
8. Maheswaran, S. et al. Detection of mutations in EGFR in circulating lung-cancer cells. N. Engl. J. Med. 359, 366-377 (2008).
9. Heitzer, E. et al. Complex tumor genomes inferred from single circulating tumor cells by array-CGH and next-generation sequencing. Cancer Res. 73, 2965-2975 (2013).
10. Ni, X. et al. Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc. Natl. Acad. Sci. USA 110, 21083-21088 (2013).
11. Yu, M. et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature 487, 510-513 (2012).
12. Allard, W.J. et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin. Cancer Res. 10, 6897-6904 (2004).
13. Swennenhuis, J.F. et al. Effciency of whole genome amplifcation of single circulating tumor cells enriched by CellSearch and sorted by FACS. Genome Med. 5, 106 (2013).
14. Hou, Y. et al. Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148, 873-885 (2012).
15. Zong, C. et al. Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338, 1622-1626 (2012).
16. Cann, G.M. et al. mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer. PLoS ONE 7, e49144 (2012).
17. El Gammal, A.T. et al. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin. Cancer Res. 16, 56-64 (2010).
18. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
19. Grasso, C.S. et al. The mutational landscape of lethal castration-resistant prostate cancer. Nature 487, 239-243 (2012).
20. Beltran, H. et al. New strategies in prostate cancer: translating genomics into the clinic. Clin. Cancer Res. 19, 517-523 (2013).
21. Ross, R.W. et al. Predictors of prostate cancer tissue acquisition by an undirected core bone marrow biopsy in metastatic castration-resistant prostate cancer-a Cancer and Leukemia Group B study. Clin. Cancer Res. 11, 8109-8113 (2005).
22. Robbins, C.M. et al. Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors. Genome Res. 21, 47-55 (2011).
23. Nickerson, M.L. et al. Somatic alterations contributing to metastasis of a castration-resistant prostate cancer. Hum. Mutat. 34, 1231-1241 (2013).
24. Gerlinger, M. et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. N. Engl. J. Med. 366, 883-892 (2012).
25. Chapman, P.B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med. 364, 2507-2516 (2011).
26. Heinrich, M.C. et al. Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J. Clin. Oncol. 21, 4342-4349 (2003).
27. Lindberg, J. et al. Exome sequencing of prostate cancer supports the hypothesis of independent tumour origins. Eur. Urol. 63, 347-353 (2013).
28. Gole, J. et al. Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells. Nat. Biotechnol. 31, 1126-1132 (2013).
29. Murtaza, M. et al. Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature 497, 108-112 (2013).
30. Barbieri, C.E. et al. Exome sequencing identifes recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer. Nat. Genet. 44, 685-689 (2012).
31. Oh, W.K. et al. Development of an integrated prostate cancer research information system. Clin. Genitourin. Cancer 5, 61-66 (2006).
32. Love, J.C. et al. A microengraving method for rapid selection of single cells producing antigen-specifc antibodies. Nat. Biotechnol. 24, 703-707 (2006).
33. Fisher, S. et al. A scalable, fully automated process for construction of sequence-ready human exome targeted capture libraries. Genome Biol. 12, R1 (2011).
34. Stransky, N. et al. The mutational landscape of head and neck squamous cell carcinoma. Science 333, 1157-1160 (2011).
35. Li, H. & Durbin, R. Fast and accurate long-read alignment with Burrows-Wheeler transform. Bioinformatics 26, 589-595 (2010).
36. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
37. Lawrence, M.S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214-218 (2013).
38. Shalek, A.K. et al. Single-cell transcriptomics reveals bimodality in expression and splicing in immune cells. Nature 498, 236-240 (2013).
39. Ramsköld, D. et al. Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells. Nat. Biotechnol. 30, 777-782 (2012).
40. Li, B. & Dewey, C. RSEM: accurate transcript quantifcation from RNA-Seq data with or without a reference genome. BMC Bioinformatics 12, 323 (2011).
41. Trapnell, C. et al. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).